Insider · CIK 0001339358
Fred E Cohen
directorowner
Files at CDNA (CareDx, Inc.), NTLA (Intellia Therapeutics, Inc.), KYTX (Kyverna Therapeutics, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 13, 2025 | CDNA CareDx, Inc. | AGrant or award Common Stock | +12,103 | $0.00 | $0 | 155,265 | Jun 17, 2025 |
| Jun 11, 2025 | NTLA Intellia Therapeutics, Inc. | AGrant or award Common Stock | +8,000 | $0.00 | $0 | 57,453 | Jun 13, 2025 |
| Jun 11, 2025 | NTLA Intellia Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +11,450 | $0.00 | $0 | 11,450 | Jun 13, 2025 |
| May 29, 2025 | KYTX Kyverna Therapeutics, Inc. | AGrant or award Common Stock | +16,634 | $0.00 | $0 | 16,634 | Jun 2, 2025 |
| May 29, 2025 | KYTX Kyverna Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +65,351 | $0.00 | $0 | 65,351 | Jun 2, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.